GlassScriptPhysician profile
Marco Ferrara
NPI 1083973408
$35,553.36
in general payments reported to CMS, 2019-2025
30 companies · $18K in 2025
The $18K reported for 2025 was more than what 95% of Colon & Rectal Surgery providers received nationally (typical 2025 total: $317).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $617 · 2020: $137 · 2021: $683 · 2022: $2,137 · 2023: $1,180 · 2024: $13K · 2025: $18K.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Consulting Fee: $25K · Honoraria: $4,160 · Food and Beverage: $2,781 · Gift: $19.70 · Travel and Lodging: $19.00.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Consulting Fee | $25,000.00 |
| Honoraria | $4,160.00 |
| Food and Beverage | $2,780.51 |
| Gift | $19.70 |
| Travel and Lodging | $19.00 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Ethicon INC. | $25,000.00 | 2024-2025 | |
| Davol INC. | $4,220.00 | 2025 | |
| Intuitive Surgical, INC. | $955.47 | 2019-2024 | Da Vinci Surgical System |
| Ethicon Endo-Surgery INC. | $900.00 | 2022 | |
| Medtronic, INC. | $699.60 | 2022-2024 | Interstim, Signia |
| Guard Medical INC. | $470.88 | 2023 | Npseal (5), Npseal Large, Npseal Medium |
| Thd America, INC. | $466.60 | 2019-2025 | |
| Smith+Nephew, INC. | $265.10 | 2022-2024 | Renasys Touch, Pico |
| Ethicon US, LLC | $263.46 | 2019-2025 | Vistaseal |
| Heron Therapeutics, INC. | $236.86 | 2022 | |
| Medical Device Business Services, INC. | $207.30 | 2021-2024 | Vistaseal |
| Innovation Technologies INC | $190.89 | 2022 | |
| Axonics, INC. | $190.63 | 2021-2022 | |
| Tela Bio, INC. | $186.17 | 2021-2022 | |
| Stryker Corporation | $165.28 | 2024 | 1788 |
Show all 30 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Aroa Biosurgery Incorporated | $158.19 | 2022 | |
| Pacira Pharmaceuticals Incorporated | $138.40 | 2019-2020 | |
| Convatec INC. | $138.37 | 2025 | |
| Abbvie INC. | $124.87 | 2024 | |
| Conmed Corporation | $122.75 | 2023 | Airseal |
| Olympus America INC. | $97.72 | 2019 | |
| Dilon Technologies, INC. | $97.28 | 2024-2025 | Hemoblast Bellows |
| Prescient Surgical | $88.97 | 2019 | |
| Cumberland Pharmaceuticals, INC. | $41.88 | 2019-2025 | Caldolor |
| Integra Lifesciences Corporation | $38.96 | 2025 | Integra, Surgimend, Integra Dermal Regeneration Template |
| Acell, INC. | $24.87 | 2019 | |
| Solventum Corporation | $20.07 | 2024 | V.A.C.Ulta, Prevena, V.A.C.Instill |
| Shire North American Group INC | $14.71 | 2019 | |
| Medtronic USA, INC. | $14.25 | 2020 | |
| Stimwave Technologies Incorporated | $13.83 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Marco Ferrara listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.